Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Presage’s device would allow oncologists to test potentially harmful compounds in tiny amounts before giving patients a full dose.
Portable diagnostic tools could offer a better outlook for TB patients.
Amgen and Genzyme are pursuing disruptive ways of making biological drugs.
Everything from a $125,000 genome analyzer to a credit card featuring a touch pad.
Technology might not always solve big problems, but it did get the president reëlected. The best long reads of the past year unpack the story behind the story.